Compare Merck & Co., Inc. (MRK) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Energy Select Sector SPDR Fund — how do they compare? Merck & Co., Inc. trades at $147.7 (market cap $363.98B), while Energy Select Sector SPDR Fund trades at $66.01. The key difference: Merck & Co., Inc. pays a 2.3% dividend while Energy Select Sector SPDR Fund pays none, and Energy Select Sector SPDR Fund is trading nearer its 52-week high, Merck & Co., Inc. nearer its low. Which is the better fit depends on your goals.
| MRK | XLE | |
|---|---|---|
Market Cap | $363.98B | — |
Sector | Health | — |
52-Week High | $156.43 | $65.31 |
52-Week Low | $77.60 | $42.61 |
Enterprise Value | $410.75B | — |
Dividend Yield | 2.3% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $148.49, down 1.23% on the day, with a bullish technical signal supported by moving averages. The company reported strong 2025 results with $65.01B revenue and $18.25B net income, though Q1 and Q2 2026 show losses. Recent acquisition of Terns Pharmaceuticals for $6.7B aims to bolster its oncology pipeline. Analyst consensus is strongly bullish with 67.6% buy ratings and a $157 price target, representing 5.7% upside.
Merck presents a compelling investment case with solid fundamentals and strategic acquisitions, but faces risks from patent expirations and competitive pressures. The stock offers moderate upside potential with institutional support, though investors should monitor execution of growth initiatives and pipeline developments in the competitive pharmaceutical landscape.
XLE, the Energy Select Sector SPDR ETF, trades at $64.78, up 1.12% amid bullish technical signals and strong sector momentum. The ETF benefits from rising oil prices, with Brent crude exceeding $100 per barrel due to Middle East tensions, as reported by Reuters on September 9, 2026. Technical indicators show a bullish moving average consensus, though the 6-day RSI at 78.15 suggests potential overbought conditions. Recent performance includes a 7.4% gain in August, leading sector ETFs, per ETF Trends on September 2, 2026.
Outlook remains positive driven by geopolitical supply risks and institutional optimism, with Goldman Sachs forecasting oil could reach $120 (Zacks, September 8, 2026). Key risks include oil price volatility and refining capacity constraints. The ETF's concentration in large caps like Exxon and Chevron offers stability, but investors face exposure to energy market cyclicality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
